Logo image of RGI.CA

RECO INTERNATIONAL GROUP INC (RGI.CA) Stock Fundamental Analysis

TSX-V:RGI - TSX Venture Exchange - CA75622R1001 - Common Stock - Currency: CAD

0.01  0 (-33.33%)

Fundamental Rating

1

RGI gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 8 industry peers in the Construction & Engineering industry. RGI has a bad profitability rating. Also its financial health evaluation is rather negative. RGI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year RGI has reported negative net income.
In the past year RGI had a positive cash flow from operations.
RGI.CA Yearly Net Income VS EBIT VS OCF VS FCFRGI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 200K -200K -400K -600K -800K

1.2 Ratios

RGI's Return On Assets of -45.44% is on the low side compared to the rest of the industry. RGI is outperformed by 75.00% of its industry peers.
Industry RankSector Rank
ROA -45.44%
ROE N/A
ROIC N/A
ROA(3y)-44.36%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RGI.CA Yearly ROA, ROE, ROICRGI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 100 -100 200 300

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for RGI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RGI.CA Yearly Profit, Operating, Gross MarginsRGI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 -10 -20 -30

3

2. Health

2.1 Basic Checks

RGI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RGI has about the same amount of shares outstanding.
RGI has a better debt/assets ratio than last year.
RGI.CA Yearly Shares OutstandingRGI.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M 40M
RGI.CA Yearly Total Debt VS Total AssetsRGI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500K 1M 1.5M 2M

2.2 Solvency

Based on the Altman-Z score of -4.02, we must say that RGI is in the distress zone and has some risk of bankruptcy.
RGI has a Altman-Z score of -4.02. This is in the lower half of the industry: RGI underperforms 75.00% of its industry peers.
RGI has a debt to FCF ratio of 0.26. This is a very positive value and a sign of high solvency as it would only need 0.26 years to pay back of all of its debts.
RGI has a Debt to FCF ratio of 0.26. This is amongst the best in the industry. RGI outperforms 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 0.26
Altman-Z -4.02
ROIC/WACCN/A
WACC9.1%
RGI.CA Yearly LT Debt VS Equity VS FCFRGI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 500K -500K -1M

2.3 Liquidity

RGI has a Current Ratio of 0.35. This is a bad value and indicates that RGI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.35, RGI is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
A Quick Ratio of 0.35 indicates that RGI may have some problems paying its short term obligations.
RGI has a Quick ratio of 0.35. This is in the lower half of the industry: RGI underperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
RGI.CA Yearly Current Assets VS Current LiabilitesRGI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M 2M 2.5M

1

3. Growth

3.1 Past

RGI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.56%, which is quite impressive.
The Revenue has grown by 30.10% in the past year. This is a very strong growth!
EPS 1Y (TTM)34.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
Revenue 1Y (TTM)30.1%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%123.29%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RGI.CA Yearly Revenue VS EstimatesRGI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 1M 2M 3M

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RGI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RGI.CA Price Earnings VS Forward Price EarningsRGI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than RGI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.06
EV/EBITDA N/A
RGI.CA Per share dataRGI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06 0.08

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for RGI!.
Industry RankSector Rank
Dividend Yield N/A

RECO INTERNATIONAL GROUP INC

TSX-V:RGI (5/26/2025, 7:00:00 PM)

0.01

0 (-33.33%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners38.35%
Ins Owner ChangeN/A
Market Cap496.40K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.11
P/FCF 1.06
P/OCF 1.06
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY94.16%
OCF(TTM)0.01
OCFY94.72%
SpS0.09
BVpS-0.03
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -45.44%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 10.4%
ROA(3y)-44.36%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover4.15
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 0.26
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z -4.02
F-Score7
WACC9.1%
ROIC/WACCN/A
Cap/Depr(3y)0.87%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.07%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.1%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%123.29%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y519.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y547.91%
OCF growth 3YN/A
OCF growth 5YN/A